litlas
Log inCreate account

James B. Bussel

Active 1983–2025

160
Papers
31,293
Citations
95
h-index
156
i10-index

Citations

Citations per year for James B. Bussel1984: 3 citations1985: 7 citations1986: 3 citations1987: 8 citations1988: 13 citations1989: 8 citations1990: 8 citations1991: 9 citations1992: 7 citations1993: 11 citations1994: 4 citations1995: 8 citations1996: 11 citations1997: 17 citations1998: 14 citations1999: 12 citations2000: 19 citations2001: 23 citations2002: 30 citations2003: 27 citations2004: 28 citations2005: 52 citations2006: 68 citations2007: 109 citations2008: 141 citations2009: 166 citations2010: 170 citations2011: 218 citations2012: 206 citations2013: 235 citations2014: 205 citations2015: 220 citations2016: 184 citations2017: 184 citations2018: 194 citations2019: 838 citations2020: 743 citations2021: 1,143 citations2022: 672 citations2023: 462 citations2024: 754 citations2025: 332 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,506 citing papers, 25.2% of this breakdownUnited Kingdom: 461 citing papers, 7.7% of this breakdownChina: 455 citing papers, 7.6% of this breakdownItaly: 364 citing papers, 6.1% of this breakdownGermany: 333 citing papers, 5.6% of this breakdownFrance: 315 citing papers, 5.3% of this breakdownCanada: 290 citing papers, 4.9% of this breakdownSpain: 189 citing papers, 3.2% of this breakdownNetherlands: 188 citing papers, 3.1% of this breakdownAustralia: 158 citing papers, 2.6% of this breakdownJapan: 158 citing papers, 2.6% of this breakdownSwitzerland: 130 citing papers, 2.2% of this breakdown
0%25.2%Other 23.9%

Institutions

Fields

  • Medicine74.5%
  • Immunology and Microbiology18.2%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Neuroscience0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Chemistry0.2%
  • Other1.3%

Topics

  • Platelet Disorders and Treatments15%
  • Blood groups and transfusion9.2%
  • Heparin-Induced Thrombocytopenia and Thrombosis3.7%
  • Immunodeficiency and Autoimmune Disorders3.1%
  • T-cell and B-cell Immunology2.8%
  • Immune Cell Function and Interaction2.5%
  • Other63.7%

Coauthors

All papers

Open in search
  1. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

    Authors: Drew Provan, Donald M. Arnold, James B. Bussel, Beng H. Chong, Nichola Cooper, Terry Gernsheimer, Waleed Ghanima, Bertrand Godeau, Tomás José González‐López, John D. Grainger, Ming Hou, Caroline Kruse, Vickie McDonald, Marc Michel, Adrian C. Newland, Sue Pavord, Francesco Rodeghiero, Marie Scully, Yoshiaki Tomiyama, Raymond Wong, Francesco Zaja, David J. Kuter - Blood Advances 2019 cited by 1,090

  2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Authors: Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, Marc Michel, Drew Provan, Donald M. Arnold, James B. Bussel, Douglas B. Cines, Beng H. Chong, Nichola Cooper, Bertrand Godeau, Klaus Lechner, Maria Gabriella Mazzucconi, Robert McMillan, Miguel Á. Sanz, Paul Imbach, Victor S. Blanchette, Thomas Kühne, Marco Ruggeri, James N. George - Blood 2008 cited by 2,660

  3. International consensus report on the investigation and management of primary immune thrombocytopenia

    Authors: Drew Provan, Roberto Stasi, Adrian C. Newland, Victor S. Blanchette, Paula Bolton‐Maggs, James B. Bussel, Beng H. Chong, Douglas B. Cines, Terry Gernsheimer, Bertrand Godeau, John D. Grainger, Ian Greer, Beverley J. Hunt, Paul Imbach, G. Lyons, Robert McMillan, Francesco Rodeghiero, Miguel Á. Sanz, Michael D. Tarantino, Shirley Watson, Joan Young, David J. Kuter - Blood 2009 cited by 2,267

  4. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

    Authors: James B. Bussel, Donald M. Arnold, Elliot Grossbard, Jiřı́ Mayer, Jacek Treliński, Wojciech Homenda, Andrzej Hellmann, Jerzy Windyga, Liliya Sivcheva, Alhossain A. Khalafallah, Francesco Zaja, Nichola Cooper, Vadim Markovtsov, Hany Zayed, Anne‐Marie Duliège - American Journal of Hematology 2018 cited by 351

  5. Thrombopoietin receptor agonists: ten years later

    Authors: Waleed Ghanima, Nichola Cooper, Francesco Rodeghiero, Bertrand Godeau, James B. Bussel - Haematologica 2019 cited by 390

  6. B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

    Authors: Irene Puga, Montserrat Cols, Carolina Barra, Bing He, Linda Cassis, Maurizio Gentile, Laura Comerma, Alejo Chorny, Meimei Shan, Weifeng Xu, Giuliana Magri, Daniel M. Knowles, Wayne Tam, April Chiu, James B. Bussel, Sergi Serrano, José A. Lorente, Beatríz Bellosillo, Josep Lloreta, Núria Juanpere, Francesc Alameda, Teresa Baró, Cristina Díaz de Heredia, Núria Torán, Albert Català, Montserrat Torrebadell, Clàudia Fortuny, V. Cusí, Carmen Carreras, George A. Díaz, J. Magarian Blander, Claire‐Michèle Farber, Guido Silvestri, Charlotte Cunningham‐Rundles, Michaela Calvillo, Carlo Dufour, Lucia Dora Notarangelo, Vassilios Lougaris, Alessandro Plebani, Jean‐Laurent Casanova, Stephanie Ganal, Andreas Diefenbach, Juan I. Aróstegui, Manel Juan, Jordi Yagüe, Nizar Mahlaoui, Jean Donadieu, Kang Chen, Andrea Cerutti - Nature Immunology 2011 cited by 721

  7. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

    Authors: Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, Monica Carpenedo, David J. Kuter, Hanny Al‐Samkari, James B. Bussel, Marie Godar, Jaume Ayguasanosa, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian C. Newland, Michael Fillitz, Paul Knoebl, Stef Meers, Ismail Amine, Jaromír Gumulec, Antonín Hluší, Jiřı́ Mayer, Philippe Quittet, Jean‐François Viallard, M Betaneli, I Datikashvili-David, Genadi Iosava, Levan Makhaldiani, László Rejtő, Nino Sharashenidze, Stefanie Groepper, Alexander Röth, Aryan Hamed, Árpád Illés, Monica Carpenedo, Andrea Artoni, Monica Bocchia, Barbara Gamberi, Alessandra Borchiellini, Esther Natalie Olíva, Andrea Patriarca, Simona Tomassetti, Yoshitaka Miyakawa, Kiyoshi Ando, Hiroshi Handa, Shinya Katsutani, Kaichi Nishiwaki, Shoko Ito, Tomoki� Ito, Fransien de Boer, A.J. Gerard Jansen, Hanna Ciepłuch, Szymon Fornagiel, Sebastian Grosicki, Maria Soroka‐Wojtaszko, Jacek Treliński, Б. А. Бакиров, Elena Borisenkova, Elena Volodicheva, Yuri Shatokhin, Andrey Proydakov, Maria Aranzazu Alonso, María Eva Mingot‐Castellano, Blanca Sánchez‐González, Blanca Sanchez-Gonzalez, Meltem Aylı, Tuba Hacıbekiroğlu, Ahmet Muzaffer Demir, Meliha Nalçacı, Mehmet Sönmez, Anıl Tombak, Selami Koçak Toprak, Burhan Turgut, Filiz Vural, Münci Yağcı, Fevzi Altuntaş, Mehmet Turgut, Emın Kaya, Nataliya Romanyuk, Vickie McDonald, Syed Rashid Saeed Kazmi, Catherine M. Broome, Spero R. Cataland, Ketan Doshi, Steven R. Lentz, Michael Boxer, Richard Rosenberg, Michael Boxer, Richard Rosenberg - The Lancet 2023 cited by 91

  8. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention

    Authors: Dhavalkumar D. Patel, James B. Bussel - Journal of Allergy and Clinical Immunology 2020 cited by 150

  9. The ITP syndrome: pathogenic and clinical diversity

    Authors: Douglas B. Cines, James B. Bussel, Howard A. Liebman, Eline T. Luning Prak - Blood 2009 cited by 802

  10. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

    Authors: David J. Kuter, James B. Bussel, Roger M. Lyons, Vinod Pullarkat, Terry Gernsheimer, Francis M. Senecal, Louis M. Aledort, James N. George, Craig M. Kessler, Miguel Á. Sanz, Howard A. Liebman, Frank T. Slovick, J. Th. M. de Wolf, Emmanuelle Bourgeois, Troy H. Guthrie, Adrian C. Newland, Jeffrey S. Wasser, Solomon I. Hamburg, Carlos Grande, François Lefrère, Alan Lichtin, Michael D. Tarantino, Howard R. Terebelo, Jean‐François Viallard, Francis J. Cuevas, Ronald S. Go, David H. Henry, Robert L. Redner, Lawrence Rice, Martin R. Schipperus, Ding‐Ding Guo, Janet L. Nichol - The Lancet 2008 cited by 862

  11. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn

    Authors: Kenneth J. Moise, Leona E. Ling, Dick Oepkes, Eleonor Tiblad, E. J. T. Verweij, Enrico Lopriore, John Smoleniec, Ulrich J. Sachs, Gregor Bein, Mark D. Kilby, Russell S. Miller, Roland Devlieger, François Audibert, Stephen P. Emery, Kara B. Markham, Mary E. Norton, Olga Ocón‐Hernández, Pranav Pandya, Leonardo Pereira, Robert M. Silver, Rory Windrim, James B. Streisand, Jocelyn H. Leu, Arpana Mirza, Valerie Smith, Lisa Barrie Schwartz, May Lee Tjoa, Shumyla Saeed-Khawaja, Yosuke Komatsu, James B. Bussel - New England Journal of Medicine 2024 cited by 91

  12. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

    Authors: Weili Bao, James B. Bussel, Susanne Heck, Wu He, Marissa Karpoff, Nayla Boulad, Karina Yazdanbakhsh - Blood 2010 cited by 339

  13. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study

    Authors: Raymond Wong, Mansoor N. Saleh, Abderrahim Khélif, Abdulgabar Salama, Maria Socorro O Portella, Paul Burgess, James B. Bussel - Blood 2017 cited by 310

  14. Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program

    Authors: James B. Bussel, Donald M. Arnold, Michael Boxer, Nichola Cooper, Jiřı́ Mayer, Hany Zayed, Sandra Tong, Anne‐Marie Duliège - American Journal of Hematology 2019 cited by 120

  15. The role of CD8+ T cell clones in immune thrombocytopenia

    Authors: Amna Malik, Anwar A. Sayed, Panpan Han, Michelle MH Tan, Eleanor Watt, Adela Constantinescu‐Bercu, Alexander T.H. Cocker, Ahmad Khoder, Rocel C. Saputil, Emma Thorley, Ariam Teklemichael, Yunchuan Ding, Alice C J Hart, Haiyu Zhang, Wayne Mitchell, Nesrina Imami, James T. B. Crawley, Isabelle I. Salles‐Crawley, James B. Bussel, James L. Zehnder, Stuart Adams, Bing Zhang, Nichola Cooper - Blood 2023 cited by 54

  16. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

    Authors: Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher, Sandra Y. Vasey, Bhabita Mayer, Manuel Aivado, M. Arning, Nicole L. Stone, James B. Bussel - The Lancet 2010 cited by 582

  17. Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

    Authors: Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kießling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles - Blood Advances 2020 cited by 110

  18. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment

    Authors: Oriana Miltiadous, Ming Hou, James B. Bussel - Blood 2019 cited by 217

  19. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City

    Authors: Alain Borczuk, Steven Salvatore, Surya V. Seshan, Sanjay S. Patel, James B. Bussel, Maria Mostyka, Sarah Elsoukkary, Bing He, Claudia Del Vecchio, Francesco Fortarezza, Federica Pezzuto, Paolo Navalesi, Andrea Crisanti, Mary Fowkes, Clare Bryce, Fiorella Calabrese, Mary Beth Beasley - Modern Pathology 2020 cited by 478

  20. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia

    Authors: James B. Bussel, David J. Kuter, Louis M. Aledort, Craig M. Kessler, Adam Cuker, Kelly Pendergrass, Shande Tang, Joe McIntosh - Blood 2014 cited by 162

  21. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

    Authors: David J. Kuter, James B. Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P. Lambert, Howard A. Liebman, Michael D. Tarantino, Michelle Lee, Hailing Guo, Ahmed Daak - Therapeutic Advances in Hematology 2023 cited by 32

  22. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

    Authors: James B. Bussel, Gregory Cheng, Mansoor N. Saleh, Bethan Psaila, Lidia Kovaleva, Balkis Meddeb, Janusz Kłoczko, Habib Hassani, Bhabita Mayer, Nicole L. Stone, M. Arning, Drew Provan, J.M. Jenkins - New England Journal of Medicine 2007 cited by 805

  23. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

    Authors: Elisa Lucchini, Francesco Zaja, James B. Bussel - Haematologica 2019 cited by 111

  24. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

    Authors: Anna J. Podolanczuk, Alan H. Lazarus, Andrew R. Crow, Elliot Grossbard, James B. Bussel - Blood 2008 cited by 272